Schaeffer's Top Stock Picks for '25

Genocea Stock Halved; JPMorgan Chase Gets Downgraded

Cheesecake Factory could struggle to compete with the food delivery sector, according to one brokerage firm

Managing Editor
Sep 26, 2017 at 10:17 AM
facebook X logo linkedin


Analysts are weighing in on bank stock JPMorgan Chase & Co. (NYSE:JPM), restaurant chain Cheesecake Factory Inc (NASDAQ:CAKE), and biotech Genocea Biosciences Inc (NASDAQ:GNCA). Here's a quick roundup of today's bearish brokerage notes on shares of JPM, CAKE, and GNCA.

Deutsche Bank Downgrades JPMorgan Chase

Deutsche Bank downgraded JPMorgan Chase to "hold" from "buy," saying the Fed's plan to gradually raise interest rates may not boost bank stocks, and that "increased competition in investment banking/trading may erode some of JPM's recent gains." Nevertheless, the brokerage firm raised its price target to $96 from $90 -- though this sits just a hair above the equity's current perch -- while Instinet raised its JPM target price to $87 from $86.

At last check, JPM stock was down 0.3% to trade at $93.83, but it has added nearly 43% year-over-year, and last Thursday touched a new record high of $95.37. Analyst sentiment remains split, though. At last night's close, nine of the 17 brokerages covering JPM rated the stock a "hold," while the other eight said it was a "strong buy."

Store Traffic Concerns Spark Cheesecake Factory Stock Downgrade

CAKE is down 1.9% to trade at $40.81, after Wedbush downgraded it to "neutral" from "outperform," and slashed its price target from $44 to $52. The brokerage firm cited concerns over declining store traffic and growth in the food delivery sector as reasons for the downgrade.

Today's price action is just more of the same, considering CAKE stock has shed 40% since topping out at a record high of $67.14 in early May -- with its 30-day moving average provide stiff resistance since May. Plus, the equity touched a four-year low of $38.34 on Sept. 7. 

Some of this downside is likely a result of increased selling pressure from shorts. Short interest is up 17.4% from the May 1 reporting period to 9.84 million shares -- 23.25% of the stock's available float.

Genocea Stock Gutted After Layoffs, Drug Halt

Genocea Biosciences stock is down a whopping 65.5% to trade at $1.84, earlier hitting a new record low of $1.64, after the drug developer reduced its staff by 40%, and halted progress on its genital herpes treatment GEN-003, which was in late-stage clinical trials. As a result, Stifel downgraded GNCA to a "hold" from "buy," while reducing its price target to $2.50 from $15. Cowen and Company also issued a price-target cut, to $10 from $40.

While GNCA is currently short-sale restricted, short sellers have flocked to GNCA. Short interest increased by 8% during the last two reporting periods to 4.62 million shares. These bearish bets are at their highest point since June 2016, and represent a whopping one-fifth of GNCA's total available float.

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter